Evidence map›Paper›PMID 38110357›Full record

ArticleNature communications2023

Intranasal mask for protecting the respiratory tract against viral aerosols.

Xiaoming Hu, Shuang Wang, Shaotong Fu, Meng Qin, Chengliang Lyu, Zhaowen Ding, Yan Wang, Yishu Wang, Dongshu Wang, Li Zhu and 13 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Fine mapping and candidate gene analysis of qPH19.1, a locus for soybean (Glycine max L.) plant height.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 1 country.

Xiaoming Hu *State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 100190, Beijing, China.
Shuang Wang *State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 100190, Beijing, China.ORCID http://orcid.org/0000-0002-9189-602X
Shaotong Fu *School of Chemical Engineering, University of Chinese Academy of Sciences, 100049, Beijing, China.
Meng QinBeijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, 100029, Beijing, China.
Chengliang LyuState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 100190, Beijing, China.ORCID http://orcid.org/0000-0002-3999-3199
Zhaowen DingState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 100190, Beijing, China.ORCID http://orcid.org/0000-0002-2362-7530
Yan WangState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 100190, Beijing, China.
Yishu WangState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 100190, Beijing, China.
Dongshu WangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology, 100071, Beijing, China.
Li ZhuState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology, 100071, Beijing, China.
Tao JiangState Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 100071, Beijing, China.ORCID http://orcid.org/0000-0003-1908-2926
Jing SunInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, 100029, Beijing, China.
Hui DingShenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Department of Otolaryngology, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, 518035, Shenzhen, China.
Jie WuState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 100190, Beijing, China.
Lingqian ChangKey Laboratory of Biomechanics and Mechanobiology, Ministry of Education Beijing Advanced Innovation Center for Biomedical Engineering School of Biological Science and Medical Engineering, Beihang University, 100083, Beijing, China.
Yimin CuiDepartment of Pharmacy, Peking University First Hospital, 100034, Beijing, China.
Xiaocong PangDepartment of Pharmacy, Peking University First Hospital, 100034, Beijing, China.
Youchun WangDivision of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, 102629, Beijing, China.ORCID http://orcid.org/0000-0001-9769-5141
Weijin HuangDivision of HIV/AIDS and Sex-Transmitted Virus Vaccines, Institute for Biological Product Control, National Institutes for Food and Drug Control (NIFDC) and WHO Collaborating Center for Standardization and Evaluation of Biologicals, 102629, Beijing, China.ORCID http://orcid.org/0000-0002-4246-8889
Peidong YangDepartment of Breast Surgery, Affiliated Quanzhou First Hospital of Fujian Medical University, 362000, Quanzhou, China.
Limin WangSchool of Chemical Engineering, University of Chinese Academy of Sciences, 100049, Beijing, China. lmwang@ipe.ac.cn.ORCID http://orcid.org/0000-0003-2543-3622
Guanghui MaState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 100190, Beijing, China. ghma@ipe.ac.cn.ORCID http://orcid.org/0000-0001-9154-5556
Wei WeiState Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, 100190, Beijing, China. weiwei@ipe.ac.cn.ORCID http://orcid.org/0000-0002-6244-3187
Institute of Process Engineering · CNPeking University · CNBeihang University · CNBeijing University of Chemical Technology · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNFujian Medical University · CNInstitute of Microbiology · CNNational Institutes for Food and Drug Control · CNShenzhen Second People's Hospital · CN

Funding

Beijing Nova Program 20230484335National Natural Science Foundation of China (National Science Foundation of China) 21821005National Natural Science Foundation of China (National Science Foundation of China) 22108284National Natural Science Foundation of China (National Science Foundation of China) 32030062National Natural Science Foundation of China (National Science Foundation of China) 82102205National Natural Science Foundation of China (National Science Foundation of China) T2225021National Natural Science Foundation of China (National Science Foundation of China) U2001224Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) JQ21027
6 · The paper itself

Abstract

The spread of many infectious diseases relies on aerosol transmission to the respiratory tract. Here we design an intranasal mask comprising a positively-charged thermosensitive hydrogel and cell-derived micro-sized vesicles with a specific viral receptor. We show that the positively charged hydrogel intercepts negatively charged viral aerosols, while the viral receptor on vesicles mediates the entrapment of viruses for inactivation. We demonstrate that when displaying matched viral receptors, the intranasal masks protect the nasal cavity and lung of mice from either severe acute respiratory syndrome coronavirus 2 or influenza A virus. With computerized tomography images of human nasal cavity, we further conduct computational fluid dynamics simulation and three-dimensional printing of an anatomically accurate human nasal cavity, which is connected to human lung organoids to generate a human respiratory tract model. Both simulative and experimental results support the suitability of intranasal masks in humans, as the likelihood of viral respiratory infections induced by different variant strains is dramatically reduced.

Indexed as

Respiratory Aerosols and DropletsVirus DiseasesAdministration, IntranasalAerosolsAnimalsHumansHydrogelsMiceRespiratory SystemAerosolsHydrogels

Identifiers

PMID38110357
PMCPMC10728126
OpenAlexW4389894070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.